(0.16%) 5 222.68 points
(0.32%) 39 513 points
(-0.03%) 16 341 points
(-1.34%) $78.20
(-2.13%) $2.25
(1.14%) $2 366.90
(0.11%) $28.40
(1.48%) $1 005.50
(0.11%) $0.928
(-0.30%) $10.83
(-0.01%) $0.798
(-0.42%) $92.15
3 days till quarter result
(bmo 2024-05-14)
Expected move: +/- 0.00%
Live Chart Being Loaded With Signals
Senti Biosciences, Inc. operates as a gene circuit company. The company develops cell and gene therapies engineered with gene circuits that are designed to reprogram cells with biological logic to sense inputs, compute decisions, and respond to respective cellular environments...
Stats | |
---|---|
Today's Volume | 62 230.00 |
Average Volume | 117 283 |
Market Cap | 16.88M |
EPS | $0 ( 2024-03-27 ) |
Next earnings date | ( $-0.230 ) 2024-05-14 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.200 |
ATR14 | $0.0100 (2.71%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-04 | Li Yvonne | Buy | 0 | |
2024-02-01 | Rajangam Kanya | Buy | 152 000 | Stock Option (Right to Buy) |
2024-02-01 | Rajangam Kanya | Buy | 101 000 | Common Stock |
2024-02-01 | Lu Timothy K | Buy | 306 000 | Common Stock |
2024-02-01 | Lu Timothy K | Buy | 459 000 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
6.93 |
Last 74 transactions |
Buy: 8 676 991 | Sell: 33 461 793 |
Volume Correlation
Senti Biosciences, Inc. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Senti Biosciences, Inc. Correlation - Currency/Commodity
Senti Biosciences, Inc. Financials
Annual | 2023 |
Revenue: | $2.56M |
Gross Profit: | $-2.68M (-104.76 %) |
EPS: | $-2.09 |
FY | 2023 |
Revenue: | $2.56M |
Gross Profit: | $-2.68M (-104.76 %) |
EPS: | $-2.09 |
FY | 2022 |
Revenue: | $4.29M |
Gross Profit: | $366 000 (8.54 %) |
EPS: | $-1.750 |
FY | 2021 |
Revenue: | $2.29M |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-1.267 |
Financial Reports:
No articles found.
Senti Biosciences, Inc.
Senti Biosciences, Inc. operates as a gene circuit company. The company develops cell and gene therapies engineered with gene circuits that are designed to reprogram cells with biological logic to sense inputs, compute decisions, and respond to respective cellular environments. Its synthetic biology platform utilizes off-the-shelf chimeric antigen receptor natural killer (CAR-NK) cells to target particularly challenging liquid and solid tumor oncology indications. The company's lead programs include SENTI-202, a Logic Gated OR+NOT off-the-shelf CAR-NK cell therapy designed to target and eliminate acute myeloid leukemia (AML) cells, while sparing the healthy bone marrow; and SENTI-301, a multi-armed off-the-shelf CAR-NK cell therapy designed for the treatment of hepatocellular carcinoma (HCC). It also develops SENTI-401, a Logic Gated (NOT) off-the-shelf CAR-NK cell therapy designed to target and eliminate colorectal cancer (CRC) cells, while sparing healthy cells in the body. The company was founded in 2016 and is based in South San Francisco, California.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators